Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical losartan for corneal scarring (Phase II)
jRCTs061260058Phase 2Recruiting
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of losartan in corneal fibrosis. Primary endpoint: Change in best-corrected visual acuity at 6 months. Started Aug 2026; status: recruiting.
02
Drugs
losartan
03
Conditions
corneal fibrosis
Beyond the preview
Go deeper on jRCTs061260058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061260058.